LUZ FIGUEROA-ESCALERA: Open Payments
NPI 1629483300 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 50 payments from 17 companies in 2025. Trend: 2023 $1,659 · 2024 $1,448 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $170 |
| PFIZER INC. | 7 | $150 |
| Esperion Therapeutics, Inc. | 7 | $138 |
| AstraZeneca Pharmaceuticals LP | 4 | $90 |
| Novo Nordisk Inc | 4 | $83 |
| Amgen Inc. | 4 | $73 |
| Alnylam Pharmaceuticals Inc. | 2 | $72 |
| Abbott Laboratories | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
Products named: LEQVIO, NEXLETOL, ELIQUIS, REPATHA, ONPATTRO, Wegovy, WAINUA, CARDIOMEMS.
Industry payments across FL — which companies pay providers there.
